Evaluation of a dietary screener: the Mediterranean Eating Pattern for Americans tool.

BACKGROUND: Evidence exists for an association between accordance with a Mediterranean diet pattern and slower rates of cognitive decline. However, an 'Americanised' version of the Mediterranean diet screener is needed to assess accordance in the USA. Thus, the Mediterranean Eating Pattern for Americans (MEPA) tool was developed to assess accordance with a Mediterranean-like food pattern when time is limited. The present study aimed to determine whether the MEPA screener captured the key elements of the Mediterranean diet compared to the more comprehensive food frequency questionnaire (FFQ). METHODS: The study comprised a cross-sectional study in which 70 women completed both the VioScreen™ FFQ (Viocare, Princeton, NJ, USA) electronically and the 16-item MEPA screener, either electronically or by telephone, aiming to evaluate the inter-method reliability of the proposed screener. The convenience sample included patients (n = 49) and healthcare providers (n = 21) recruited from a tertiary care medical centre. RESULTS: The overall score from the MEPA screener correlated with corresponding overall MEPA FFQ score (ρ = 0.365, P = 0.002). Agreement between screener items and FFQ items was moderate-to-good for berries (κ = 0.47, P < 0.001), nuts (κ = 0.42, P < 0.001), fish (κ = 0.62, P < 0.001) and alcohol (κ = 0.64, P < 0.001), whereas those for olive oil (κ = 0.33, P = 0.001) and green leafy vegetables (κ = 0.36, P = 0.0021) were fair. Usual intakes of potassium, magnesium, vitamin C, saturated fat, selected carotenoids, folate and fibre derived from the FFQ varied with MEPA screener scores in the anticipated directions. CONCLUSIONS: The MEPA screener captures several components of the Mediterranean style pattern, although further testing of the MEPA screener is indicated.

Cardiac rhythm disturbances among children with idiopathic congenital central hypoventilation syndrome.

The objective of this study was to determine whether subjects with congenital central hypoventilation syndrome (CCHS) had an increased frequency of cardiac arrhythmias and decreased heart rate variability when compared to subjects without a known deficit in control of breathing, and that these abnormalities would be exaggerated by anesthesia. Continuous ambulatory Holter recordings were obtained in patients with CCHS and compared to two otherwise healthy control groups without a deficit in control of breathing: one with an intact airway (n = 11) and a second group with a tracheostomy (n = 6). Holter recordings were obtained before, during (under general anesthesia), and after bronchoscopy. Fourteen children with CCHS (age: 9.3 +/- 4.4 years mean +/- S.D.) were studied, and 7 underwent bronchoscopy. Seventeen control children were studied (age 6.6 +/- 3.6 years): 11 without a tracheostomy, and 6 with a tracheostomy who also underwent bronchoscopy. Maximum heart rate during baseline recording was significantly lower in the CCHS subjects as compared to controls (P = 0.0001). At baseline the difference in the number of arrhythmias/24 hr/subject in all CCHS vs. all control subjects was significant (P = 0.0002); for the subjects who had bronchoscopy, CCHS vs. control, the difference was also significant (P = 0.03). In addition, there was a significant decrease in the number of events/24 hr/subject among the CCHS subjects between baseline and post-bronchoscopy (P = 0.0288). The predominant arrhythmias were sinus bradycardia and transient asystole. The longest asystole in a CCHS subject was 6.50 sec, and in a control subject, 1.42 sec (at baseline the means of the longest asystole were 2.69 +/- 1.4 vs. 1.24 +/- 0.13; P = 0.003 in the CCHS vs. control groups). Other indices of heart rate variability were significantly reduced in the CCHS subjects (P < 0.05). These results substantiate our hypothesis that subjects with CCHS have more arrhythmias than controls, an increased frequency of bradyarrhythmias, and decreased cyclical sinus arrhythmia.

Characteristics of the signal-averaged P wave in orthotopic heart transplant recipients.

UNLABELLED: Rejection remains the Achilles heel of orthotopic cardiac transplantation (OHT). Reliable noninvasive markers of rejection are desirable for timely therapy and to reduce risks and costs. Changes in atrial electrophysiology may precede ventricular changes during acute rejection. Although P wave duration in the signal-averaged ECG reflects atrial conduction, the feasibility of such measurement and the range of its values in OHT patients in absence of rejection is uncertain. This study compared the filtered P wave duration in 15 hypertensive OHT patients free of rejection with that in 15 age-matched hypertensive controls. All OHT patients had biatrial anastomoses. Two electrophysiologists interpreted the tracings independently. Three tracings (2 OHT, 1 control) could not be interpreted by either reader. An adequate P wave signal-averaged ECG was obtained in the remaining patients, despite the frequent presence of dissociated P waves (recipient and donor atria) on standard ECG in OHT patients. There was good interobserver agreement in the measurement of filtered P wave duration (r = 0.91; P < 0.0001). CONCLUSIONS: The filtered P wave duration was significantly shorter in the OHT patients (112 +/- 15 ms versus 128 +/- 14 ms; P = 0.008). Filtered P wave duration can be measured in most OHT. Filtered P wave duration is shorter in OHT patients than in hypertensive controls, possibly as a result of the reduced mass of the truncated donor atria. Further studies are needed to determine whether the signal-averaged P wave can be useful to predict acute cardiac rejection.

Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation.

OBJECTIVES: This multicenter study compared the efficacy and safety of ibutilide versus procainamide for conversion of recent-onset atrial flutter or fibrillation. BACKGROUND: Ibutilide fumarate is an intravenous (IV) class III antiarrhythmic agent that has been shown to be significantly more effective than placebo in the pharmacologic conversion of atrial flutter and fibrillation to sinus rhythm. Procainamide is commonly used for conversion of recent-onset atrial fibrillation to normal sinus rhythm. METHODS: One hundred twenty-seven patients (age range 22 to 92 years) with atrial flutter or fibrillation of 3 h to 90 days' (mean 21 days) duration were randomized to receive either two 10-min IV infusions of 1 mg of ibutilide fumarate, separated by a 10-min infusion of 5% dextrose in sterile water, or three successive 10-min IV infusions of 400 mg of procainamide hydrochloride. RESULTS: Of the 127 patients, 120 were evaluated for efficacy: 35 (58.3%) of 60 in the ibutilide group compared with 11 (18.3%) of 60 in the procainamide group had successful termination within 1.5 h of treatment (p < 0.0001). Seven patients were found to have violated the protocol and were not included in the final evaluation. In the patients with atrial flutter, ibutilide had a significantly higher success rate than procainamide (76% [13 of 17] vs. 14% [3 of 22], p=0.001). Similarly, in the atrial fibrillation group, ibutilide had a significantly higher success rate than procainamide (51% [22 of 43] vs. 21% [8 of 38], p=0.005). One patient who received ibutilide, which was found to be a protocol violation, had sustained polymorphic ventricular tachycardia requiring direct current cardioversion. Seven patients who received procainamide became hypotensive. CONCLUSIONS: This study establishes the superior efficacy of ibutilide over procainamide when administered to patients to convert either atrial fibrillation or atrial flutter to sinus rhythm. Hypotension was the major adverse effect seen with procainamide. A low incidence of serious proarrhythmia was seen with the administration of ibutilide occurring at the end of infusion.

Effect of left atrial size on recurrence of atrial fibrillation after electrical cardioversion: atrial dimension versus volume.

UNLABELLED: There are conflicting reports on the relationship between left atrial dimension (LAD) determined by echo-cardiography and the incidence of atrial fibrillation (AF) recurrence after electrical cardioversion (EC). We hypothesized that left atrial volume (LAV) by echocardiography might better differentiate patients who will have recurrence of AF after EC. METHODS: Forty-one patients having EC for AF were prospectively studied by echocardiography. LAD was measured by American Society of Echocardiography guidelines as the anterior-posterior dimension in the parasternal view. LAV was measured by Simpson's method using an off-line analysis system and reported as the average of values from the apical four-chamber and two-chamber views. RESULTS: (Data are mean +/- SEM): Patient follow-up was 15 +/- 10 months. No cutoff value of LAV predicted AF recurrence, but all three patients with LAD greater than 65 mm had AF recurrence. Compared with patients maintaining normal sinus rhythm (NSR) (N = 18), the AF group (N = 23) had a lower percentage of antiarrhythmic drug use, especially type IA agents (p < .02). Patients who stayed in NSR tended to have shorter AF duration before EC (16 +/- 15 v 63 +/- 122 weeks, p = .08) but did not differ in age (53 +/- 27 v 58 +/- 23 years), LAD (51.1 +/- 7.7 v 54.2 +/- 9.4 mm) or LAV (85.1 +/- 24.3 v 95.1 +/- 33.3 mL). CONCLUSIONS: (1) LAV by echocardiography does not improve identification of patients at risk for recurrence of AF after EC, (2) patients with LAD up to 65 mm may maintain NSR after EC, (3) LAD greater than 65 mm is associated with AF recurrence, and (4) use of antiarrhythmic drugs and the duration of AF before EC may be better predictors of maintenance of NSR than echocardiographic measures of left atrial parameters.

Does atrial fibrillation cause false-positive late potentials?

We hypothesized that atrial fibrillation may cause false-positive late potentials due to the recording of baseline atrial activity. We performed signal-averaged ECGs in 26 patients with atrial fibrillation before and after conversion to normal sinus rhythm. Signal-averaged ECGs were recorded for > 200 cycles with a noise level of < or = 0.5 microV. The signals were band-pass filtered at 40-250 Hz. We examined filtered QRS duration (fQRS), duration of low amplitude signal < 40 microV (LAS), and the root mean square (RMS) of the terminal 40 msec of the QRS complex. A late potential was considered present when two of the following three criteria were met: fQRS > or = 114 msec, LAS > or = 38 msec, and RMS < or = 20 microV. The mean +/- standard deviation of the fQRS in atrial fibrillation and sinus rhythm were 113 +/- 28 and 110 +/- 25 msec; of the LAS 38 +/- 17 and 37 +/- 15 msec; of the RMS 27 +/- 22 and 28 +/- 21 microV; of the noise 0.25 +/- 0.08 and 0.22 +/- 0.07 microV (P = NS). Ten signal-averaged ECGs in atrial fibrillation had late potentials. With reversion to sinus rhythm one of these 26 patients gained a late potential; two others lost a late potential (P = NS by McNemar's Chi-square). There was no significant difference in the signal-averaged ECG parameters or noise levels. In conclusion, signal-averaged ECG parameters are not significantly changed by cardioversion of atrial fibrillation to normal sinus rhythm.(ABSTRACT TRUNCATED AT 250 WORDS)

Beneficial effects of dextro-amphetamine in the treatment of vasodepressor syncope.

Three patients with history of documented hypotension, near syncope, or syncope before or after the administration of isoproterenol during head-up tilt table are reported. Severe bradycardia was also noted in one patient. All three patients responded to the administration of 2.5 mg of oral dextroamphetamine 45 minutes prior to a repeat head-up tilt table study. The potent central and peripheral adrenergic agonist pharmacological properties of this drug permitted the prevention of severe vasodepressor syncope in these patients.

Repeated inhalation of nebulized albuterol did not induce arrhythmias in a patient with Wolff-Parkinson-White syndrome and asthma.

It has been assumed that in asthmatic patients with Wolff-Parkinson-White (WPW) syndrome, ablative therapy for the condition is necessary for the safe treatment of the asthma with beta 2-adrenergic drugs. The following case report illustrates that inhaled albuterol was safely administered to an asthmatic patient with electrocardiographic evidence of preexcitation, without the need of an ablative procedure. This case report is, to our knowledge, the first in the literature in which the cardiac rhythm of a patient with WPW syndrome was monitored during repeated inhalations of a beta 2-agonist.

In anterior myocardial infarction, frequency domain is better than time domain analysis of the signal-averaged ECG for identifying patients at risk for sustained ventricular tachycardia.

Low amplitude signals at the end of the QRS in patients with prior myocardial infarction (MI) are related to fragmentation of the electrical impulse in ventricular myocardium and are known to correlate with an increased risk of sustained ventricular tachycardia (VT). We hypothesized that in patients with anterior MI (AMI), earlier activation of the damaged anterior wall would cause an earlier fragmentation of the signal-averaged ECG (SAECG) signal, making conventional time domain analysis of late potentials difficult. We performed SAECG in 213 patients (62 with AMI and 58 with inferior MI [IMI]). Fifty-seven had prior sustained VT; 23 with AMI and 24 with IMI. We examined the standard time domain SAECG parameters including the duration of the filtered QRS (40-250 Hz), the duration of the late QRS < 40 microV, and the root mean square amplitude of the last 40 msec of the QRS. We also examined the power law scaling (PLS) in the frequency domain. Receiver operating characteristic curve analysis of a discriminant function demonstrated significant differences for PLS as compared to time domain indices. An important finding was the significance of MI locus in the time domain indices. PLS did not exhibit this dependence. These data suggest that the usual indices are insufficient for identifying AMI patients at risk of VT. PLS, on the other hand, is valuable regardless of MI location.

Reproducibility of programmed electrical stimulation responses in patients with ventricular tachycardia or fibrillation associated with coronary artery disease.

Invasive electrophysiologic studies were performed in 102 patients with sustained ventricular tachycardia (VT) or ventricular fibrillation (VF) using an aggressive programmed electrical stimulation (PES) protocol. The study was repeated after 2.0 +/- 2.9 days in all patients with no intercurrent changes in antiarrhythmic therapy. Patients with coronary artery disease (n = 72) were identified and PES results of these patients were analyzed and compared with results of patients without coronary artery disease. Multiple clinical and electrophysiologic factors were analyzed to determine any association with concordance of PES responses. No significant difference in concordance of PES responses was found in the 2 groups of patients. PES responses were groups into 3 categories: (1) noninducible, (2) nonsustained VT, and (3) sustained VT. Kappa values of PES responses of noninducible and sustained VT in both groups were higher and therefore the PES responses were more reproducible than nonsustained VT. The induction of sustained monomorphic VT was more reproducible than a PES response of nonsustained or sustained polymorphic VT. Inducible sustained VT with a rate of greater than or equal to 250 beats/min was less reproducible than induction of sustained VT with a rate less than 250 beats/min. Induction of VT by 3 extrastimuli was less reproducible than with any other mode. This short-term variability may account for false negatives associated with PES-directed antiarrhythmic therapy. Because of these findings, it is recommended that nonsustained VT and sustained polymorphic or rapid polymorphic VT should not be used as PES end points to guide antiarrhythmic therapy.